Selected Publications
-
article
- Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.. Annals of the rheumatic diseases. 83:1436-1442. 2024
- The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study.. The Lancet. Rheumatology. 6:e771-e779. 2024
- Web Exclusive. Annals On Call - Diagnosing Giant Cell Arteritis.. Annals of internal medicine. 177:-. 2024
- Patient-Reported Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Are the Answers in Front of Our Noses?. Arthritis care & research. 76:1353-1354. 2024
- Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica.. Rheumatic diseases clinics of North America. 50:255-267. 2024
- Current perspective on infections and mitigation strategies in primary systemic vasculitis.. Current rheumatology reports. 26:279-289. 2024
- Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.. Annals of the rheumatic diseases. 83:48-57. 2024
- Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide.. Arthritis care & research. 76:288-294. 2023
- Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the ACR Rheumatology Informatics System for Effectiveness registry.. Arthritis care & research. 76:259-264. 2023
- Association of patient copayment and medication adherence in systemic lupus erythematosus.. Lupus science & medicine. 10. 2023
- Early referral of patients with suspected polymyalgia rheumatica - A systematic review.. Seminars in arthritis and rheumatism. -. 2023
- An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.. Rheumatology (Oxford, England). 62:2797-2805. 2023
- Erratum to "Social media for research discourse, dissemination, and collaboration in rheumatology".. Rheumatology and immunology research. 4:107-108. 2023
- Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries.. Lupus science & medicine. 10. 2023
- Should race be considered in diagnosing giant cell arteritis? - Authors' reply.. The Lancet. Rheumatology. 5:e372-e373. 2023
- Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status.. Rheumatology (Oxford, England). 62:1621-1626. 2023
- Giant cell arteritis can occur in people of colour.. The Lancet. Rheumatology. 5:e175-e177. 2023
- Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019.. Rheumatic diseases clinics of North America. 49:695-711. 2023
- Navigating use of rituximab during the COVID-19 pandemic.. The Lancet. Rheumatology. 5:e63-e64. 2023
- Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?. Seminars in arthritis and rheumatism. -. 2022
- Supporting International Medical Graduates in Rheumatology: A Call to Action.. Arthritis & rheumatology (Hoboken, N.J.). 75:145-148. 2022
- Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia.. Rheumatology (Oxford, England). 61:4455-4464. 2022
- Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.. The Journal of rheumatology. 50:3-5. 2022
- Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.. RMD open. 8. 2022
- Omicron breakthrough infections in patients with immune-mediated inflammatory diseases.. The Lancet. Rheumatology. 4:e751-e752. 2022
- Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured.. Arthritis research & therapy. 24:-. 2022
- Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database.. Seminars in arthritis and rheumatism. -. 2022
- Where do we go after GiACTA?. Rheumatology (Oxford, England). 61:2720-2721. 2022
- Baseline Factors Associated with Self-reported Disease Flares Following COVID-19 Vaccination among Adults with Systemic Rheumatic Disease: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.. Rheumatology (Oxford, England). 61:SI143-SI150. 2022
- Response to Letter to the Editor: Comment on the Review Article: "ANCA-Associated Vasculitis in Latin America. A systematic Literature Review: About Their Epidemiology and Their Clinical Features" by Victor R. Pimentel-Quiroz, et al. (J Clin Rheumatol 2022;28:44-51).. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 28:e682-e683. 2022
- SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.. Arthritis & rheumatology (Hoboken, N.J.). 74:766-775. 2022
- Clinical Features of ANCA-Associated Vasculitis in African American Patients in the United States: A Single-Center Medical Records Review Study.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 28:212-216. 2022
- The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey.. Rheumatology advances in practice. 6:-. 2022
- COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.. The Lancet. Rheumatology. 4:e237-e240. 2022
- Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset.. ACR open rheumatology. 4:300-305. 2022
- ANCA-Associated Vasculitis in Latin America: A Systematic Literature Review: About Their Epidemiology and Their Clinical Features.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 28:44-51. 2022
- Dr. Conway et al reply.. The Journal of rheumatology. 49:120-121. 2022
- Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees.. ACR open rheumatology. 4:128-133. 2021
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.. The Lancet. Rheumatology. 3:e855-e864. 2021
- COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.. The Journal of rheumatology. 49:110-114. 2021
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.. RMD open. 7. 2021
- The role of immunomodulatory medications in the treatment of COVID-19.. Current opinion in rheumatology. 33:431-445. 2021
- Reply.. Arthritis & rheumatology (Hoboken, N.J.). 73:1767-1768. 2021
- The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World.. The Journal of rheumatology. 48:1501-1503. 2021
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.. The Lancet. Rheumatology. 3:e707-e714. 2021
- Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.. Seminars in arthritis and rheumatism. 51:1139-1145. 2021
- Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.. Arthritis & rheumatology (Hoboken, N.J.). 73:1514-1522. 2021
- Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events.. Rheumatology (Oxford, England). 60:e184-e185. 2021
- Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.. Seminars in arthritis and rheumatism. 51:292-298. 2021
- Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'.. Expert review of clinical immunology. 17:105-107. 2020
- Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.. The Lancet. Rheumatology. 3:e71-e82. 2020
- Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.. Arthritis & rheumatology (Hoboken, N.J.). 73:36-47. 2020
- Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.. Arthritis & rheumatology (Hoboken, N.J.). 72:1990-1997. 2020
- Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review.. The Journal of rheumatology. 48:1053-1059. 2020
- Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.. Expert review of clinical immunology. 16:659-666. 2020
- Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis.. Seminars in arthritis and rheumatism. 50:988-995. 2020
- Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment.. Current allergy and asthma reports. 20:-. 2020
- Festina lente. Annals of the rheumatic diseases. 79:734-736. 2020
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.. Annals of internal medicine. 172:819-821. 2020
- Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?. Rheumatic diseases clinics of North America. 45:379-398. 2019
- The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.. Contemporary clinical trials. 238-44. 2016
- Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications.. Therapeutic advances in musculoskeletal disease. 8:145-59. 2016
- A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study.. Contemporary clinical trials communications. 32-38. 2016
- Fracture mortality: associations with epidemiology and osteoporosis treatment.. Nature reviews. Endocrinology. 10:592-602. 2014
- Comorbidities in patients with crystal diseases and hyperuricemia.. Rheumatic diseases clinics of North America. 40:251-78. 2014
- Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.. Clinical therapeutics. 35:1850-61.e1. 2013
- Cryopreservation modulates the detection of regulatory T cell markers.. Cytometry. Part B, Clinical cytometry. 82:54-8. 2011